Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Prepaid Assets (2010 - 2026)

Innoviva's (INVA) quarterly Prepaid Assets came in at $24.8 million in Q1 2026, up 7836.74% YoY from $313000.0 in Q1 2025, and up 1417.53% on a QoQ basis from $1.6 million in Q4 2025.

Analysis

Innoviva (INVA) Prepaid Assets (2010 - 2026) Analysis & Trends

Innoviva (INVA) has 17 years of Prepaid Assets data on file, last reported at $24.8 million in Q1 2026.

  • Quarterly Prepaid Assets rose 7836.74% year-over-year to $24.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.8 million (up 7836.74% YoY) and the FY2025 annual result came in at $1.6 million, down 92.23% from the prior year.
  • Prepaid Assets rose to $24.8 million in Q1 2026, from $1.6 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $24.8 million in Q1 2026 to a low of $181000.0 in Q2 2025.
  • A 5-year average of $8.6 million and a median of $2.9 million in 2022 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2025 — Prepaid Assets sank 97.87% — and 2026, when it jumped 7836.74%.
  • Tracing INVA's Prepaid Assets over 5 years: stood at $2.9 million in 2022, then jumped by 637.47% to $21.6 million in 2023, then decreased by 2.62% to $21.1 million in 2024, then plunged by 92.23% to $1.6 million in 2025, then soared by 1417.53% to $24.8 million in 2026.
  • The last three Prepaid Assets figures came in at $24.8 million (Q1 2026), $1.6 million (Q4 2025), and $19.4 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.41 Mn
Mar 31, 2026 24.84 Mn
Dec 31, 2025 26.72 Mn
Sep 30, 2025 19.42 Mn
Jun 30, 2025 16.61 Mn
Mar 31, 2025 15.41 Mn
Dec 31, 2024 21.06 Mn
Sep 30, 2024 12.65 Mn
Jun 30, 2024 8.48 Mn
Mar 31, 2024 16.55 Mn
Dec 31, 2023 21.63 Mn
Sep 30, 2023 14.73 Mn
Jun 30, 2023 20.54 Mn
Mar 31, 2023 24.12 Mn
Dec 31, 2022 29.56 Mn
Sep 30, 2022 7.93 Mn
Jun 30, 2022 3.95 Mn
Mar 31, 2022 5.58 Mn
Dec 31, 2021 1.37 Mn
Sep 30, 2021 542,000.00